Google's Antigravity AgentKit adds modular skills and a UI Pro Max Scale, helping you ship cleaner designs faster ...
As Amgen waits for an FDA decision on a second indication for its B cell-depleting therapy Uplizna, it has new data suggesting a third may be coming down the pipe. New data from the phase 3 MINT trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback